Skip to main content
SpringerLink
Log in

To the Editor: The Role of Prophylactic Surgery in Cancer Prevention

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. You YN, Lakhani VT, Wells SA (2007) The role of prophylactic surgery in cancer prevention. World J Surg 31:450–464

    Article  PubMed  Google Scholar 

  2. U.S.Preventive Services Task Force (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 143:355–361

    Google Scholar 

  3. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, version 1.2007. Hereditary Breast and/or Ovarian Genetic Assessment. http://www.nccn.com. Accessed 01.08.2007 at http://www.nccn.org

  4. Roukos DH, Murray S, Briasoulis E (2007) Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer. Cancer Biol Ther 6:308–312

    PubMed  CAS  Google Scholar 

  5. Parkin DM, Bray F, Ferlay J, et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  6. Roukos DH, Kappas AM, Tsianos E (2002) Role of surgery in the prophylaxis of hereditary cancer syndromes. Ann Surg Oncol 9:607–609

    PubMed  Google Scholar 

  7. Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656–1663

    Article  PubMed  Google Scholar 

  8. Roukos DH, Agnanti NJ, Paraskevaidis E, et al. (2002) Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations. Ann Surg Oncol 9:941–943

    PubMed  Google Scholar 

  9. Kauff ND, Barakat RR (2007) Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J Clin Oncol 10(25):2921–2927

    Article  CAS  Google Scholar 

  10. Agnantis NJ, Paraskevaidis E, Roukos D (2004) Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance. Ann Surg Oncol 11:1030–1034

    Article  PubMed  Google Scholar 

  11. Roukos DH, Briasoulis E (2007) Individualized preventive and therapeutic management of hereditary breast ovarian cancer. Nat Clin Pract Oncol 4(10):578–590

    Article  PubMed  CAS  Google Scholar 

  12. Fatouros M, Baltoyiannis G, Roukos DH (2007) The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations. Ann Surg Oncol [Epub ahead of print] doi:10.1245/s10434-007-9612-4

  13. Norton JA, Ham CM, Van Dam J, et al. (2007) CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 245:873–879

    Article  PubMed  Google Scholar 

  14. Chung DC, Yoon SS, Lauwers GY, et al. (2007) Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer. N Engl J Med 19(357):283–291

    Article  Google Scholar 

  15. Huntsman DG, Carneiro F, Lewis FR, et al. (2001) Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 344:1904–1909

    Article  PubMed  CAS  Google Scholar 

  16. Lewis FR, Mellinger JD, Hayashi A, et al. (2001) Prophylactic total gastrectomy for familial gastric cancer. Surgery 130:612–617

    Article  PubMed  CAS  Google Scholar 

  17. Roukos DH (2004) Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol 11:127–129

    Article  PubMed  Google Scholar 

  18. Sano T (2007) Tailoring treatments for curable gastric cancer. Br J Surg 94:263–264

    Article  PubMed  CAS  Google Scholar 

  19. Roukos DH, Hottenrott C, Encke A, et al. (1994) Primary gastric lymphomas: a clinicopathologic study with literature review. Surg Oncol 3:115–125

    Article  PubMed  CAS  Google Scholar 

  20. Roukos DH. (2000) Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7:253–255

    Article  PubMed  CAS  Google Scholar 

  21. Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM (2001). Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer 84(12):1602–1609

    Article  PubMed  CAS  Google Scholar 

  22. Siewert JR, Bottcher K, Stein HJ, et al. (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449–461

    Article  PubMed  CAS  Google Scholar 

  23. Roukos DH, Kappas AM (2002) Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 81:59–62

    Article  PubMed  Google Scholar 

  24. Roukos DH, Hottenrott C, Lorenz M, et al. (1990) A critical-evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach—an analysis of early results and long-term survival. J Cancer Res Clin 116:307–313

    Article  CAS  Google Scholar 

  25. Kappas AM, Fatouros M, Roukos DH (2004) Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11:727–730

    Article  PubMed  Google Scholar 

  26. Roukos DH (1998) Extended lymphadenectomy in gastric cancer: when, for whom and why. Ann R Coll Surg Engl 80:16–24

    PubMed  CAS  Google Scholar 

  27. Macdonald JS, Smalley SR, Benedetti J, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

    Article  PubMed  CAS  Google Scholar 

  28. Roukos DH. (2002) Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9:220–221

    Article  PubMed  Google Scholar 

  29. Roukos DH, Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2:98–107

    Article  PubMed  Google Scholar 

  30. Cunningham D, Allum WH, Stenning SP, et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 355:11–20

    Article  PubMed  CAS  Google Scholar 

  31. Briasoulis E, Fatouros M, Roukos DH (2007) Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14(10):2691–2695

    Article  PubMed  Google Scholar 

  32. Roukos DH (2007) Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357(15):1555–1556

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Ioannina University Medical School, Ioannina, Greece

    Michael Fatouros & Georgios Baltogiannis

Authors
  1. Michael Fatouros
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Georgios Baltogiannis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Fatouros.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fatouros, M., Baltogiannis, G. To the Editor: The Role of Prophylactic Surgery in Cancer Prevention. World J Surg 32, 1219–1220 (2008). https://doi.org/10.1007/s00268-007-9283-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-007-9283-0

Keywords

Search

Navigation